Position in PFE
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$536,261
-$86,974 QoQ
Shares Held
22,270
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,707
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERICAN NATIONAL BANK & TRUST holds $79,015,646 across 10 Drug Manufacturers - General names. PFE ranks #6 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
90,625 | $23,016,031 | |
| 2 | ABBV |
AbbVie Inc.
|
77,067 | $19,393,139 | |
| 3 | LLY |
ELI LILLY & Co
|
15,875 | $19,040,952 | |
| 4 | AMGN |
Amgen Inc
|
34,999 | $12,673,837 | |
| 5 | MRK |
Merck & Co., Inc.
|
26,998 | $3,469,243 | |
| 6 | PFE |
Pfizer Inc
This page
|
22,270 | $536,261 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,578 | $452,044 | |
| 8 | NVS |
Novartis AG
|
1,786 | $279,901 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $536,261 | 22,270 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $623,235 | 22,195 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $602,007 | 24,177 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $629,050 | 24,688 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $740,847 | 30,563 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $781,815 | 30,853 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $2,990,435 | 112,719 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $3,178,364 | 109,826 | Shares | Sole | 2024-10-02 | |
| 2024-06-30 | $3,147,274 | 112,483 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $3,139,579 | 113,138 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $1,614,744 | 56,087 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $6,558,803 | 197,733 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $6,967,696 | 189,959 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $10,172,745 | 249,332 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $9,967,665 | 194,529 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $8,555,430 | 195,508 | Shares | Sole | 2022-10-05 | |
| 2022-06-30 | $10,705,104 | 204,179 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $10,756,667 | 207,778 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $13,166,732 | 222,976 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $9,690,239 | 225,302 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $8,856,934 | 226,173 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $8,379,564 | 231,288 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $6,176,349 | 167,790 | Shares | Sole | 2021-01-06 | |
| 2020-09-30 | $6,493,911 | 176,946 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $5,065,169 | 154,898 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $5,622,852 | 172,269 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||